Hizentra is an Ig* therapy that provides proven PI protection with the convenience of self-administration, so you can focus on everyday living
With Hizentra, an IV is not involved. Hizentra treats primary immune deficiency (PI) with subcutaneous infusions, which means you can self-administer by infusing just under the skin, not into a vein, after receiving training from your doctor.
Hizentra gives you steady Ig levels for consistent PI protection, with less volume per dose plus flexible dosing options to fit your lifestyle (from daily to once every 2 weeks).
Hizentra is a prescription medicine used to treat PI in patients 2 years and older.
These programs feature a presentation from a trained nurse who treats
PI and stories from a PI patient just like you. Watch a video below to learn more.
With Premier Start, you can receive:
The Hizentra Co-Pay Relief program helps eligible people afford their therapy by assisting with monthly out-of-pocket expenses for Hizentra (up to $5,000 for each year, with no monthly cap). Most patients with commercial insurance pay $0 out-of-pocket.See if you are eligible
CSL Behring Assurance is a program that can help eligible patients continue to receive treatment even if they experience a lapse in third-party private health insurance.Learn how it works